Kaplan–Meier survival curve analysis showed that the prognosis of LGG and GBM patients with high WEE2-AS1 expression was significantly poorer than that of those with low expression in all three glioma datasets (Fig. 3B). This evidence concerns the gene WEE2 and glioblastoma.